CompletedNot Applicable

Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania

Tanzania58 participantsStarted 2024-03-01

Plain-language summary

Investigators will adapt the Brief Social Behaviour and Network Therapy (B-SBNT) intervention developed to facilitate recovery among people receiving medication-assisted treatment for opioid use disorder in the United Kingdom. The B-SBNT involves families and the wider social networks of people receiving medications for opioid use disorder to support recovery. Key components of the intervention include: mapping the social networks of clients; inviting others identified through the mapping to participate in the intervention; building communication strategies with network members; and developing joint activities with network members. In the original B-SBNT, the intervention is delivered by therapists/clinicians who undergo training. Investigators will pilot test the adapted version of this intervention with a maximum of 80 people: 20 current clients receiving methadone maintenance treatment (MMT) at the Muhimbili National Hospital (MNH) Medically-Assisted Treatment (MAT) Clinic and up to 60 social support persons identified by recruited MMT clients. The pilot will assess the social network intervention's acceptability and feasibility.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria for MMT client participants in the intervention pilot: * 18 years old or older, * currently enrolled in the MAT program at the Muhimbili MAT clinic, * prescribed methadone for the past 3 months, * received a positive test result for heroin, cannabis or alcohol use in the past 3 months, * provide consent for trial participation. Inclusion criteria for social support persons in the intervention pilot: * 18 years old or older, * identified as a social support person of a MMT client participating in the pilot trial * lives in Dar es Salaam, * provide consent for trial participation. Exclusion Criteria: * Does not meet inclusion criteria

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Participants Who Attend Week 1 Intervention Session

Timeframe: Week 1 of intervention

MMT Participants Who Attend Week 2 Intervention Session

Timeframe: Week 2 of intervention

Participants Who Attend Week 3 Intervention Session

Timeframe: Week 3 of intervention

MMT Participants Who Attend Week 4 Intervention Session

Timeframe: Week 4 of intervention

Participants Who Attend Week 5 Intervention Session

Timeframe: Week 5 of intervention

Participants Who Attend Week 6 Intervention Session

Timeframe: Week 6 of intervention

Number of Intervention Counselors Who Adhered to the Intervention Manual

Timeframe: On average, 1 month post-intervention

Trial details

NCT IDNCT04479475

SponsorJohns Hopkins Bloomberg School of Public Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-05

Results submitted2025-09-02

View on ClinicalTrials.gov More Opioid-use Disorder trials